0
0
9/6/22 at 1:48pm
Organization
Forbes
Author
William A. Haseltine
37 words
0
Comments
The P2G3 antibody is the latest in a long line of potential SARS-CoV-2 monoclonal antibody treatments to neutralize a broad range of viral variants.
You are the first to view
https://www.forbes.com/sites/williamhaseltine/2022/09/06/progress-in-the-search-for-broadly-neutralizing-monoclonal-antibodies-vii/
Create an account
or login to join the discussion